311 SUPEROVULATION OF NORTH AMERICAN BISON WITH TWO INJECTIONS OF FOLLICLE-STIMULATING HORMONE

2013 ◽  
Vol 25 (1) ◽  
pp. 302
Author(s):  
J. P. Barfield ◽  
G. E. Seidel

Few studies have examined superovulation of North American Bison. In cattle, ovarian superstimulation is usually achieved with 6 to 8 injections of FSH at half-day intervals. However, handling bison repeatedly stresses the animals, which could adversely affect their reproductive potential, as well as pose a risk of injury to the bison and handlers. To limit the number of times the bison were handled, we tested a two-injection superovulation scheme using sodium hyaluronate (MAP-5, Bioniche Animal Health Inc., Belleville, Ontario, Canada) in the FSH diluent, which serves to slow the absorption of FSH when given IM. We hypothesised that the two-injection superstimulation protocol would result in recovery of more embryos on average than a single-embryo recovery protocol. Although a traditional superovulation scheme with 6 to 8 injections of FSH would have been a better comparison, our goal was to handle the bison minimally. Eight female bison ranging in age from 5 to 11 years were used as embryo donors. For superovulation, females with a corpus luteum (CL) were given 25 mg of prostaglandin F2α (PGF, Lutalyse, Pfizer Animal Health, New York, NY, USA) IM followed by 266 mg of FSH (Folltropin V in MAP-5 diluent, i.m., Bioniche Animal Health Inc.) 12 days later (or 9 days after presumed oestrus 3 days post-PGF). Forty-eight hours after the first FSH injection, 134 mg of FSH IM and 25 mg of PGF IM were given. Two days later females were put in a pen with a bison bull for natural breeding. Seven days after assumed oestrus, embryos were recovered nonsurgically. Although the situation is not clear in bison, there is evidence in cattle that superovulated cycles influence embryo collections in subsequent cycles. Consequently, females were randomly assigned to a superovulation or single-embryo recovery treatment for each cycle; however, consecutive superovulation protocols were never conducted without a short oestrous cycle in between. Superovulated females were given PGF at embryo recovery after superovulation, followed by PGF 12 to 14 days later, and bred off the assumed oestrus of the second PGF injection. Embryos were collected from females 4 times (2 superovulation and 2 single embryo cycles, except one bison that was superovulated once). Data were analysed using a one-tailed t-test. Superovulation resulted in greater mean numbers of palpable CL (3.7; P < 0.001), embryos collected (1.8; P < 0.05), and transferable quality embryos (0.8; P < 0.05) compared with the single-embryo recovery protocol (mean palpable CL, 1.0; embryos collected, 0.5; transferable embryos, 0.2). Notably, the bison breeding season is July to September and occasionally animals breed in October; this experiment was conducted in October and November. Thirteen transferable embryos were nonsurgically transferred to recipients; 6 pregnancies were established, but 5 were resorbing by 2 months of gestation; 1 healthy calf was carried to term. Two injections of FSH with a long-acting diluent can be used to increase the number of embryos recovered from bison compared with a single-embryo recovery scheme.

2009 ◽  
Vol 21 (1) ◽  
pp. 243 ◽  
Author(s):  
P. W. Farin ◽  
K. M. Dowdall ◽  
J. E. Hicks ◽  
C. E. Farin ◽  
C. S. Whisnant

Follicle stimulating hormone (FSH) is usually administered in a series of intramuscular (IM) injections to induce multiple ovulations for embryo production in cattle and other species. The objective of this study was to determine the superovulatory response of dairy cows to subcutaneous (SC) administration of FSH using a reduced number of injections in combination with a progesterone-releasing device. Eighteen non-lactating Holstein cows initially received 25 mg Prostaglandin F2α IM (PGF; Lutalyse; Pfizer Animal Health, Groton, CT, USA) on Day –7. All cows then received an intravaginal progesterone-releasing device (CIDR-B, 1.38 mg progesterone; Pfizer Animal Health) on Day 0, and 100 μg GnRH IM (Cystorelin; Merial Ltd, USA) on Day 2. Cows were randomly assigned to receive a total of 400 mg (20 mL) of FSH (Folltropin-V; Bioniche Animal Health, USA) either by IM injection (IM Group, n = 9 cows) given at 12 h intervals on Days 4 (60 mg, 60 mg), 5 (55 mg, 55 mg), 6 (45 mg, 45 mg) and 7 (40 mg, 40 mg), or by SC injection (SC Group, n = 9 cows) given at 24 h intervals on Days 4 (140 mg), 5 (140 mg) and Day 6 (120 mg). On Day 7, CIDR-B inserts were removed and cows received two 25 mg PGF IM injections given 12 h apart. Cows were artificially inseminated at 12 and 24 h after standing estrus. Blood samples were obtained from all cows at 0, 2, 4, 8, 12, 24, 36, 48, 60, 72, and 84 h after the first FSH injection for determination of serum FSH concentrations. Ovarian follicles and CL were monitored using ultrasonography on Days 4, 7, and 16. Embryos were recovered non-surgically on Day 16 (7 days after estrus). The effects of treatment on follicular response and embryo yield were analyzed by Wilcoxon test, and the response of cows to treatment was analyzed by chi-square test. The effects of treatment on concentrations of serum FSH were analyzed using ANOVA for repeated measures. There was no effect (P > 0.05) of route of FSH administration on the concentrations of serum FSH at any time point. The superovulatory response of cows to treatment, defined as greater than 2 CL per cow, did not differ (P > 0.05) between the IM (77.8%, 7/9 cows) and SC (88.9%, 8/9 cows) Groups. There was also no difference (P > 0.05) between the IM and SC Groups for the number of 5 to 10 mm follicles prior to FSH treatment (mean ± SEM; 0.6 ± 0.2 v. 0.9 ± 0.4), the total number of follicles after FSH treatment (12.4 ± 1.6 v. 12.7 ± 2.2) or the number of CL at embryo recovery (6.4 ± 1.5 v. 10.4 ± 2.1). Similarly, there were no differences (P > 0.05) between the IM and SC Groups for total number of oocytes/embryos (5.6 ± 2.6 v. 13.0 ± 4.3), transferable embryos (Grade 1, 2, 3; 3.0 ± 1.4 v. 6.1 ± 2.9) or Grade 1 embryos (2.9 ± 1.4 v. 4.3 ± 2.5). In conclusion, administration of FSH using 3 SC injections in combination with a progesterone-releasing device was an effective method for superovulation of Holstein cows. Supported by USDA Animal Health Formula Funds and the State of North Carolina.


2009 ◽  
Vol 21 (1) ◽  
pp. 169
Author(s):  
R. Dupras ◽  
Y. Chorfi

The objective of this study was to evaluate the use of a second flush for bovine embryo recovery. A total of 319 clinically healthy Holstein cows (247 lactating, 53 dry, 19 nulliparous) with an average age of 5.5 ± 2.5 years were used for this experiment. Superovulation was performed according to a modified method of Baracaldo et al. (2000). On Day 0 (beginning of the experiment), each cow received 3 mg of estradiol-17β intramuscularly (i.m.) and a progesterone-releasing vaginal insert (1.9 g of progesterone, CIDR, Pfizer Animal Health, Kirkland, QC, Canada) at random stages of the estrous cycle. From Day 4 evening to Day 8 evening, the cows received a total of 380 mg of NIH-FSH-P1 (FolltropinV, Bioniche Animal Health) administered im through 9 injections of decreasing dose (from 70 to 20 mg) at 12-h intervals. On Day 7, the cows received 2 injections consisting of 500 μg of cloprostenol (prostaglandin F2α analogue Estrumate, Schering-Plough, Pointe-Claire, QC, Canada) given approximately 12 h apart and vaginal inserts were removed 12 h after the last injection. Artificial insemination was performed on Day 10 after treatment with 100 μg, GnRH im (Cystorelin, Merial Canada Inc, Baie d’Urfe, QC, Canada). Embryos were flushed from the uterus of donor cows 6 days after AI. The method consisted of using simultaneously 1 catheter (18Fr Silicone 2-way, Bioniche Animal Health) per uterine horn. Catheters were maintained in place to perform 2 flushes 1 h apart. A total of 1000 mL of flushing media (Complete flush, Bioniche Animal Health) were used, 700 mL and 300 mL for the first and the second flush, respectively. Embryos were assessed for viability immediately after collection using IETS classification. Data were analyzed using the SAS MIXED procedure (SAS Institue, Cary, NC). The mean (±SD) number of embryos collected at the first flushing was 5.87 ± 5.1, 0.92 ± 2.2 and 2.9 ± 4.4 for transferable, degenerate and unfertilized oocytes, respectively. The second flushing yielded 2.32 ± 2.6 transferable embryos, 0.28 ± 0.83 dead embryos and 1.2 ± 2.2 unfertilized oocytes. There was no significant effect of age, day in milk, or stage of lactation on transferable or degenerate embryos or nonfertilized oocytes in each flushing. The embryo recovery method used in this experiment could be used to recover more transferable embryos. The authors want to thank Dr Vincent Girard for his help in statistics.


2013 ◽  
Vol 25 (1) ◽  
pp. 306
Author(s):  
K. C. Lehloenya ◽  
N. A. Mpebe ◽  
A. Gonzalez-Bulnes

This study evaluated the effect of breed and follicular status on quantity and quality of embryos recovered following superovulation in South African goats. Mature, nonlactating Boer (n = 10) and unimproved indigenous (n = 10) goats were used in this trial. Oestrous cycles of does were synchronised with controlled internal drug release (CIDR®; Pfizer Animal Health, New York, NY, USA) dispensers inserted for 9 days and injected with prostaglandin at CIDR insertion. All does were superovulated with pFSH, administered in 7 dosages, at 12 h intervals, starting from 48 h before CIDR removal. Ultrasonographic scans were performed at initiation of the superovulation treatment. Does were cervically inseminated with fresh undiluted semen at 36 and 48 h following CIDR withdrawal. Embryos were surgically collected at Day 6 following AI. The total number of recovered structures (unfertilised ova and embryos) was evaluated microscopically for the stage of development and quality, using morphological criteria. The structures were classified as unfertilised ova (if there was no cleavage), degenerate embryos (embryos at 8-cell stage and earlier stage), or as transferable grade 1, 2, and 3 embryos (morphologically intact compacted morulae, early blastocysts, and expanded blastocysts). All data were analysed using the ANOVA procedures of SAS (SAS Institute Inc., Cary, NC, USA). The time from CIDR removal to onset of oestrus did not differ significantly between breeds. Breed had no effect on the total number of corpora lutea, structures (unfertilised ova and embryos), unfertilised ova, embryos, degenerated embryos, and transferable embryos. The total number of follicles at the onset of pFSH treatment was positively correlated with the number of structures (unfertilised ova plus embryos) recovered. Similarly, the total number of embryos recovered was positively correlated with the number of follicles 2 to 3 mm and 4 to 5 mm, and the total number of follicles. The number of follicles 4 to 5 mm and the total number of follicles at the onset of pFSH treatment were positively correlated with total number of the transferrable embryos at the beginning of a superovulation treatment. The total number of transferable embryos was negatively correlated with the presence of follicles with a diameter >6 mm at the beginning of the superovulation treatment. In conclusion, breed had no effect on response to superovulation. The total number of follicles and follicle diameters 2 to 3 mm and 4 to 5 mm were positively correlated with embryo yield. The presence of follicles >6 mm at the beginning of superovulation negatively affected the quality of embryos. The results of this study indicate that breed has no effect on response to superovulation. However, the number and size of follicles at the beginning of a superovulation treatment affect both embryo yield and quality.


2013 ◽  
Vol 25 (1) ◽  
pp. 306
Author(s):  
M. E. F. Oliveira ◽  
C. C. D'Amato ◽  
C. S. Oliveira ◽  
F. F. P. C. Barros ◽  
A. P. Perini ◽  
...  

This study was designed to investigate if the time of onset of FSH treatment [near the emergence of first or last follicular wave on progesterone (P4) protocol] influenced the superovulatory response and embryo yield in Santa Ines ewes during breeding season. Days of emergence of the follicular waves were defined in a previous study that evaluated the follicular dynamic in oestrus synchronization treatments (Oliveira et al. 2011 Acta Sci. Vet. 40). We observed emergence of the first and last follicular wave on 5.69 ± 0.42 and 11.25 ± 0.39 days of protocol, respectively. Twenty Santa Ines ewes were submitted to 2 superovulatory protocols according to the time that FSH treatments were initiated (G-first wave, n = 10; G-last wave, n = 10). On Day 0, all ewes received a P4 device (CIDR®; Pfizer Animal Health, New York, NY, USA) and injection of 37.5 µg of d-cloprostenol, IM. The FSH treatments started on Day 6 and Day 11 of protocol for G-first and G-last, respectively. The superovulatory regimen consisted of 8 IM injections of pFSH administrated twice daily (40, 40, 30, 30, 20, 20, 10, and 10 mg of pFSH). The P4 device was removed on Day 8 and Day 13 for G-first and G-last, respectively. At these times, all ewes received another injection of 37.5 µg of d-cloprostenol and a dose of 200 IU of eCG. During 4 days after the P4 device removal, ewes were mated by a fertile ram. Embryo collections were accomplished 7 days after CIDR withdrawal. The ovaries were evaluated by ultrasonography (3 times daily, during the mating period) and laparotomy (concomitantly with embryo collection). The superovulatory response was observed by classified by score: 0 = 4 or fewer corpora lutea (CL); 1 = between 5 and 10 CL; and 2 = 11 or more CL. Data were analysed by GLIMMIX using SAS software (SAS Institute Inc., Cary, NC, USA). All donors from G-first had superovulatory response classified as score 2, whereas 60% of ewes from G-last were classified as score 2, 20% as score 1, and 20% as score 0 (P < 0.05). There were effects between treatments (P < 0.05) for ovulation rate (G-first: 97.9 ± 1.4% v. G-last: 88.5 ± 4.4%) and number of ovulations (G-first: 17.0 ± 2.3 v. G-last: 12.5 ± 2.6). The numbers of luteinized unovulated follicles were 0.7 ± 0.5 for G-first and 1.2 ± 0.4 for G-last (P > 0.05). There was no difference between G-first and G-last (P > 0.05) in the rate of ova/embryos recovered (54.9 ± 5.7% v. 49.3 ± 8.5%), mean number of ova/embryos recovered (9.0 ± 1.4 v. 6.3 ± 1.1), number of viable embryos (3.8 ± 1.5 v. 3.4 ± 0.8), or viability rate (40.3 ± 10.8 v. 53.4 ± 12.1). In conclusion, the FSH treatment started near the emergence of the first follicular wave of progesterone protocol in Santa Ines ewes during the breeding season resulted in a higher superovulatory response than that started near the last follicular wave; however, no improvements in embryo yield were observed. Financial support: FAPESP.


2010 ◽  
Vol 22 (1) ◽  
pp. 177
Author(s):  
M. B. Rabaglino ◽  
C. A. Risco ◽  
M. J. Thatcher ◽  
J. E. P. Santos ◽  
W. W. Thatcher

It is expected that pregnancy per AI with sexed semen would be 70 to 75% of that with conventional semen, and the use of sexed semen with timed AI (TAI) protocols is discouraged (DeJarnette et al. 2009 Theriogenology 71, 49-58). It was hypothesized that the 5-day Co-Synch + CIDR (controlled internal drug-release) protocol with 1 injection of PGF2α would be an acceptable reproductive management program for TAI of dairy heifers with sexed semen. The objectives were to compare pregnancy per TAI (P/TAI) using conventional or sexed semen for the first TAI (experiment 1), and to evaluate P/TAI of a reproductive management program with sexed semen for the first TAI and sexed or conventional semen for the second TAI (experiment 2). A total of 1,000 Holstein heifers between 13 to 14 months of age were synchronized with the 5-day Co-Synch + CIDR protocol, that consisted of an administration of GnRH (100 μg i.m. Cystorelin®, Merial Ltd., Iselin, NJ, USA) and a CIDR insert containing 1.38 g of progesterone inserted at Day 0; on Day 5 the CIDR was removed and one injection of PGF2α (25 mg, i.m. Lutalyse®, Pfizer Animal Health, New York, NY, USA) administered; on Day 8 a second injection of GnRH was administered concurrent with TAI. In experiment 1, 198 heifers were assigned randomly to be TAI with conventional (n = 98) or sexed (n = 100) semen for the first TAI. Commercial straws with sexed or conventional semen were obtained from 2 sires. In experiment 2, a total of 802 heifers received TAI to the first service with sexed semen. For the resynchronized TAI, nonpregnant heifers at 32 days after the first TAI were resynchronized with the 5-day Co-Synch + CIDR and were TAI with either sexed semen (n = 114) or with conventional semen (n = 373). Pregnancy per TAI to first and second TAI was analyzed by logistic regression using the GLIMMIX procedure of SAS (SAS Version 9.1 for Windows, SAS Institute, Cary, NC, USA) with heifer treated as a random effect. In experiment 1, P/TAI was 51.0% and 42.0% at 45 days for conventional and sexed semen, respectively (P = 0.1). Pregnancy per TAI with sexed semen was 82.3% of conventional semen. In experiment 2, P/TAI at first service with sexed semen was 35.9% at 45 days after TAI. For the second TAI, P/TAI was 40.4% with sexed semen at 45 days and 59.2% with conventional semen at 60 days (P < 0.001). As expected, P/TAI was lower with sexed compared to conventional semen. Nevertheless, the application of the 5-day Co-Synch + CIDR protocol with one injection of PGF2α, as a reproductive management program for TAI of dairy heifers, achieved an acceptable P/TAI with sexed semen. We conclude that sexed semen can be used with TAI to effectively manage reproduction in dairy heifers by removing the challenges of detection of estrus and increase the number of females born.


2010 ◽  
Vol 22 (1) ◽  
pp. 167 ◽  
Author(s):  
D. B. Carwell ◽  
J. A. Pitchford ◽  
G. T. Gentry Jr ◽  
H. Blackburn ◽  
K. R. Bondioli ◽  
...  

Artificial insemination has proven to be a valuable asset to the cattle industry. It is assumed that once good quality semen is frozen in liquid nitrogen it should remain viable indefinitely; however, semen viability has not been systematically evaluated after being stored for several decades. In this experiment, frozen semen from 25 purebred Angus bulls processed during 3 time periods (1960-1975 = 5 bulls; 1976-1991 = 11; 1992-2002 = 9 bulls) was used to randomly inseminate purebred lactating Angus cows and heifers and lactating crossbred beef cows. In experiment 1, Angus cows (n = 24) and Angus heifers (n = 16) and in experiment 2, crossbred cattle (n = 88) of 5 breeds (Beefmaster, Romosinuano, Bons Mara, Brangus, Brangus F1) were artificially inseminated with frozen-thawed Angus bulls semen from the 3 time periods. All females were in good body condition and at least 45 days postpartum and were synchronized using the SelectSynch protocol. Briefly, on treatment Day 0, females received an Eazi-Breed CIDR (Pfizer Animal Health, New York, NY, USA) implant and were administered GnRH (Factryl, 100 μg im), on Day 7, prostaglandin (Lutalyse, 25 mg im, Pfizer Animal Health) was administered and the CIDR removed. Cattle not responding to synchronization were subjected an additional prostaglandin treatment 8 to 10 days later. Estrus detection was conducted using the HeatWatch™ system for the Angus females and with Estrotect™ patches for the crossbred females. Females fitted with HeatWatch transponders that were successfully mounted 4 times within a 6-h period were considered to be in standing estrus and were inseminated 12 to 14 h later. Females fitted with Estrotect patches were observed twice daily (morning and evening) to identify females whose patch was scratched. Females were inseminated by an experienced technician 12 to 14h after the patch were observed as being scratched a minimum of 50%. Response to synchronization in Angus cows and heifers was 76% (n = 40), whereas in the crossbred cattle the response was 74% (n = 88). Cows and heifers were confirmed pregnant via transrectal ultrasonography 45 days postinsemination. Pregnancy rates confirmed by chi-square analysis were not different for Angus cows and heifers (58% and 43%, respectively). Also, pregnancy rates for the Angus females were not different across time periods 1, 2, and 3 (58, 43, and 53%, respectively). Pregnancy rates for crossbred females were not different across time periods 1, 2, and 3 (35, 60, and 44%, respectively). Overall pregnancy rates (experiments 1 and 2) were 47, 52, and 40% across time periods 1, 2, and 3 respectively. It is concluded from this study that semen units processed and frozen from Angus bulls from time periods 1, 2, and 3 (from the 1960s through to 2002) are still viable and produce similar pregnancy rates in artificially inseminated beef females. Thanks to Jared Pitchfordfor inseminating all of the cattle; Harvey Blackburn for providing the semen to make the project possible; and my advisors Dr. Gentry and Dr. Godkefor assisting throughout the entire project. I also thank all of the graduate students who have helped me throughout the project.


2014 ◽  
Vol 26 (1) ◽  
pp. 163
Author(s):  
T. L. Devine ◽  
M. L. Looper ◽  
J. H. Pryor ◽  
E. Kara ◽  
M.-C. Maurel ◽  
...  

Successful superovulation and embryo collection require donors to be managed for precise insemination intervals. At times, determinations of these intervals can become difficult because of oestrus detection subjectivity. The objective of this study was to determine the feasibility of performing a rapid cow-side LH assay (Predi′Bov®, ReproPharm, Nouzilly, France) on superovulated donors with emphasis on determining how to use the results in a commercial program to time inseminations. This study was conducted at Ovagenix (Bryan, TX, USA) on 24 superovulated donors. On Day 0 cows received an intravaginal progesterone-releasing device (CIDR®, Pfizer Animal Health, New York, NY, USA) and were administered 25 mg of progesterone and 2.5 mg of oestradiol 17β intramuscularly (IM, 2 mL). Superstimulation was induced using 150–300 mg of Folltropin-V® (FSH, Bioniche Animal Health Inc., ON, Canada) administered with 7 injections at 12-h intervals in decreasing dosages (Day 4–7). On Day 6, two doses of Estrumate® (equaling 1 mg, Intervet Inc., Merck Animal Health, Summit, NJ, USA) were given IM, concurrently with FSH injections 5 and 6 with CIDR removal on Day 7 (a.m.). HeatWatch® transmitters (Cow Chips LLC, Denver, CO, USA) were applied to donors on Day 7 to determine onset of standing oestrus. Blood samples were collected in heparinized tubes via tail vein puncture starting at CIDR removal continuing every 6 h until a positive Predi′Bov® test was acquired or 36 h after CIDR removal. Whole blood (0.5 mL–1) was submitted to a proprietary 3-step procedure using a tube-stick applicator (40 min) to determine whether increased concentrations of LH were present. Stick applicators that turned blue were positive for increased concentrations of LH. Donors were artificially inseminated 12 and 24 h after a positive test, with specified sires, and embryos were nonsurgically collected 7 days after insemination. The Predi′Bov® test determined 91.6% (22/24) of the LH peaks occurred within 12 to 24 h after CIDR removal; 45.8% (11/24) occurred at 18 h; and 4% (1/24) at 30 h. A total of 203 viable embryos (average 8.5/donor) was collected with 174 embryos (average 9.2 ± 4.7/donor) from donors that exhibited oestrus and produced a positive test (19/24; 79.2%) and 29 embryos (average 5.8 ± 6.3/donor) from donors exhibiting silent oestrus that produced a positive test (5/24; 20.8%). One donor exhibited oestrus and never produced a positive test, but contributed 8 viable embryos to the total. In conclusion, Predi′Bov® cow-side usage could offer commercial utility when identifying oestrus is difficult or nonexistent. Increased detection of ovulation could help to identify optimal AI intervals, thereby increasing embryo production and limiting the use of expensive semen for desired donors.


2010 ◽  
Vol 55 (No. 7) ◽  
pp. 353-357 ◽  
Author(s):  
B. Radisic ◽  
M. Sindicic ◽  
D. Huber ◽  
J. Kusak ◽  
T. Gomercic ◽  
...  

Reproductive control is regularly implemented in bear facilities to prevent crowding of enclosures and surplus animals. Ovariectomy may represent an efficient method of sterilizing bears yet has not been reported in the literature. A 73 kg female brown bear, age two years and three months, was anesthetized for ovariectomy with tiletamin and zolazepam (Zoletil<sup>&reg;</sup>, Virbac S.A., Carros Cedex, France) and medetomidin hydrochloride (Domitor<sup>&reg;</sup>, Pfizer Animal Health, New York, USA). A 25 cm midline incision that extended from the umbilicus to the pubic brim was made. The suspensory ligament was stretched and blunt dissected so that ovaries in bursa were exposed on the surgical field. A "Figure 8" ligature was placed between two forcepses and a circumferential ligature was placed around proximal forceps at the ovarian pedicle. Another "Figure 8" ligature was placed between two forcepses and a circumferential ligature was placed around distal forceps at the cranial tip of the uterine horn. No surgical complications occurred, and no complications have transpired during the 12 month post-operative period.


2013 ◽  
Vol 25 (1) ◽  
pp. 155
Author(s):  
P. C. S. F. Pitaluga ◽  
M. F. Sá Filho ◽  
J. N. S. Sales ◽  
P. S. Baruselli ◽  
L. Vincenti

The objective of this study was to evaluate the effect of eCG or estradiol cypionate (ECP) during the proestrus period on estrus occurrence, ovarian responses, and pregnancy per AI (P/AI) in suckled Bos indicus beef cows subjected to timed AI (TAI) protocols. A total of 393 cows in random stages of estrus (Day 0), received an intravaginal progesterone (P4) device (1.9 g of P4; CIDR®, Pfizer Animal Health, New York, NY, USA) and 2.0 mg of estradiol benzoate IM (EB; Gonadiol®, MDS Animal Health). Eight days later, the P4 devices were removed, and cows were given 0.15 mg of d-cloprostenol (Prostaglandina Tortuga®, Tortuga Companhia Zootécnica Agrária, São Paulo, Brazil). At this time, cows were randomly assigned to 1 of 3 treatments: 300 IU of eCG (Group eCG; n = 138), 300 IU of eCG plus 1 mg of ECP IM (Group eCG+ECP; n = 124), or no additional treatment (control; n = 131). Cows were timed inseminated 48 h after P4 device removal and were administrated simultaneously 100 µg of gonadorelin IM (Profertil®, Tortuga Companhia Zootécnica Agrária). A subset of cows (n = 98) were evaluated according to the occurrence of estrus between the P4 device removal and TAI and their ovarian follicles were evaluated by ultrasound at P4 device removal and corpus luteum (5 days after TAI). The data were analyzed using the GLIMMIX procedure of SAS (SAS Institute Inc., Cary, NC, USA) and differences with P < 0.05 were considered statistically significant. A greater pregnancy rate (P/AI; P = 0.04) was observed in cows receiving the eCG treatment at P4 device removal [eCG = 42% (58/138) and eCG+ECP = 50.8% (63/124)] than cows from the control group [29.8% (39/131)]. There was no additive effect of ECP supplementation on P/AI. Cows that received ECP [eCG+ECP = 56.3% (18/32)] displayed more estrus (P = 0.002) compared with those receiving eCG [eCG = 23.5% (8/34)] or only GnRH at TAI [control = 15.6% (5/32)]. In addition, regardless of the ECP supplementation, cows receiving the eCG treatment at P4 device removal [eCG = 85.3% (29/34) and eCG+ECP = 90.1% (29/32)] presented a greater ovulation rate than cows from the control group [65.6% (21/32)]. In conclusion, exogenous estradiol administrated at device removal increased the proportion of suckled Bos indicus cows that displayed estrus. Cows receiving eCG treatment (with or without estradiol supplementation) had greater ovulatory and pregnancy responses after the estradiol/P4-based synchronization protocol.


Sign in / Sign up

Export Citation Format

Share Document